Upgrade to SI Premium - Free Trial

Mira Pharma (MIRA)

0.69 +0.04 (6.15%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)

Latest Headlines

Form 8-K MIRA PHARMACEUTICALS, For: Sep 17 September 17, 2026 8:31 AM - SEC Filing MIRA Pharmaceuticals submits Ketamir-2 Phase 2a protocol for IRB review September 17, 2026 8:30 AM - StreetInsider MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review September 17, 2026 8:30 AM - StreetInsider Maxim Group Starts MIRA Pharmaceuticals Inc (MIRA) at Buy September 17, 2026 7:46 AM - StreetInsider Form 8-K MIRA PHARMACEUTICALS, For: Sep 11 September 16, 2026 4:31 PM - SEC Filing Miravalles Gold Corp. Files NI 43-101 Technical Report for Fairfield Gold Project, Nayarit, Mexico September 3, 2026 8:02 AM - StreetInsider MIRA Pharmaceuticals reports positive toxicology data for MIRA-55 pain drug September 1, 2026 8:03 AM - StreetInsider MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND September 1, 2026 8:00 AM - StreetInsider Form 10-Q MIRA PHARMACEUTICALS, For: Jun 30 August 12, 2026 4:18 PM - SEC Filing Form 8-K MIRA PHARMACEUTICALS, For: Aug 06 August 6, 2026 8:00 AM - SEC Filing MIRA Reports Positive 7-Day Dog Study Results for SKNY-1 August 6, 2026 8:00 AM - Globe NewsWire MIRA Reports Positive 7-Day Dog Study Results for SKNY-1 August 6, 2026 8:00 AM - StreetInsider Form 8-K MIRA PHARMACEUTICALS, For: Jul 27 July 31, 2026 5:00 PM - SEC Filing MIRA Pharmaceuticals completes toxicology studies for two drug candidates July 30, 2026 8:02 AM - StreetInsider MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies July 30, 2026 8:00 AM - StreetInsider Form DEF 14A MIRA PHARMACEUTICALS, For: Jul 28 July 28, 2026 5:00 PM - SEC Filing Full Article List